V005-5017 Screening compound: N-[(4-fluorophenyl)methyl]-2-{2-[(4-fluorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}pentanamide

V005-5017 Screening compound: N-[(4-fluorophenyl)methyl]-2-{2-[(4-fluorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}pentanamide
V005-5017 Screening compound: N-[(4-fluorophenyl)methyl]-2-{2-[(4-fluorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}pentanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V005-5017
N-[(4-fluorophenyl)methyl]-2-{2-[(4-fluorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}pentanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V005-5017

Molecular Formula

C26H25F2N3O (C26 H25 F2 N3 O)

Compound Name

N-[(4-fluorophenyl)methyl]-2-{2-[(4-fluorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}pentanamide

IUPAC name

N-[(4-fluorophenyl)methyl]-2-{2-[(4-fluorophenyl)methyl]-1H-13-benzodiazol-1-yl}pentanamide

SMILES

CCCC(C(NCc(cc1)ccc1F)=O)n1c(cccc2)c2nc1Cc(cc1)ccc1F

InChI

InChI=1S/C26H25F2N3O/c1-2-5-24(26(32)29-17-19-10-14-21(28)15-11-19)31-23-7-4-3-6-22(23)30-25(31)16-18-8-12-20(27)13-9-18/h3-4,6-15,24H,2,5,16-17H2,1H3,(H,29,32)/t24-/m0/s1

InChI Key

WFFCKOXFXOMYDW-DEOSSOPVSA-N

MDL Number (MFCD)

MFCD19782201

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

433.5

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

5.360

Distribution Coefficient, logD

5.360

Water Solubility, LogSw

-5.35

Polar Surface Area

35.837

Acid Dissociation Constant (pKa)

11.85

Base Dissociation Constant (pKb)

4.21

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

23.10

V005-5017 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V005-5017 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V005-5017?
Check Price and Availability of V005-5017, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V005-5017 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V005-5017
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V005-5017
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V005-5017 available by request